Clinical trial Recruiting at 1 site Interventional Ages 21 to 65

Ultrasound-guided Retrolaminar Block vs TAP Block in Laparoscopic Upper Abdominal Surgery

Official title: Safety and Efficacy of Ultrasound Guided Retrolaminar Block Versus Transverse Abdominis Plane Block on Quality of Recovery in Laparoscopic Upper Abdominal Surgeries: A Randomized Comparative Clinical Trial

Run by Mansoura University · NCT07720817 · Data updated 2026-11-12

This study tests whether retrolaminar block works as well as a TAP block to reduce pain and opioid use after laparoscopic upper abdominal surgery in adults aged 21–65.

More TAP Block trials

Quick facts

Study typeInterventional
Ages21 Years to 65 Years
SexAll
Enrollment164 (estimated)
SponsorMansoura University
Academic / other
Locations1 site (Al Mansurah, Dakahlia Governorate)
StatusRecruiting
StartedJuly 1, 2026
Main results expectedJanuary 2027
Study endsFebruary 2027
Registry record updatedSeptember 16, 2026
Trial IDNCT07720817 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 21–65 years old, ASA I–II, BMI < 30 kg/m², undergoing elective laparoscopic upper abdominal surgery under general anesthesia.

Probably not a fit

Patients with allergy to study drugs, coagulation abnormalities or infection at the block site, emergency surgeries, or significant comorbidities may not benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares two ultrasound-guided nerve blocks to manage postoperative pain after laparoscopic upper abdominal procedures. Adults aged 21 to 65 with ASA I–II and BMI under 30 kg/m² undergoing elective surgery are randomized to receive either a retrolaminar block or a TAP block. The aim is to determine safety and analgesic effectiveness, with the expectation that blocking the abdominal wall nerves will reduce opioid requirements and related side effects. The trial is conducted at Mansoura University, with the primary focus on short-term postoperative pain control and analgesic consumption. No collaborator sites are listed beyond the lead sponsor.

Why it matters

Potential benefit: If successful, patients may experience better pain control with fewer opioids after surgery, potentially leading to quicker recovery and shorter hospital stays.

How similar studies have gone: Ultrasound-guided abdominal nerve blocks are established tools for multimodal analgesia, with prior evidence supporting safety and effectiveness, though direct head-to-head comparisons like this are less common.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 21 and 65 years.
* American Society of Anesthesiologists (ASA) physical status I or II.
* Body mass index (BMI) less than 30 kg/m².
* Scheduled for elective laparoscopic upper abdominal surgery under general anesthesia.

Exclusion Criteria:

* Refusal to participate in the study.
* Known allergy or hypersensitivity to any of the study drugs.
* Infection at the planned block insertion site.
* Severe uncontrolled cardiac, renal, hepatic, neurological, or respiratory disease.
* Pre-existing chronic pain.
* Immunodeficiency.
* Coagulation abnormalities, anticoagulant therapy, or platelet count less than 80,000/µL.
* Emergency surgery.

Where it's running

  • Mansoura University
    Al Mansurah, Dakahlia Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.